Clinical Trials on High-Risk Neuroblastoma in Switzerland

Total 93 results

Array BioPharma

Completed

A Phase Ib Study of MEK162 Plus BYL719 in Adult Patients With Selected Advanced Solid Tumors

AML | Advanced and Selected Solid Tumors | High Risk and Very High Risk MDS

United States, Australia, Italy, Spain, France, Switzerland, United Kingdom
Gustave Roussy, Cancer Campus, Grand Paris

Recruiting

High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN) (HR-NBL2)

High-Risk Neuroblastoma | Patient With Insufficient Response Chemoimmunotherapy

France, Germany, Israel, Spain, United Kingdom, Belgium, Norway, Sweden, Finland, Australia, Czechia, Italy, Netherlands, Slovenia, Switzerland, Denmark, Greece, Lithuania, Slovakia
University of Zurich

Unknown

Evaluation of the Treatment Approach ROBIN (Robin)

Clinical High Risk for Psychosis

Switzerland
Balgrist University Hospital
Industry (Schülke & Mayr AG, Switzerland and Germany)

Recruiting

General Decolonization With Octenisan® Set Before Elective Orthopedic Surgery (BALGDEC)

Elective Surgery | High Risk | Prevention of Surgical Site Infections | Randomized-controlled Trial

Switzerland
Rene Kahn

Completed

Placebo-controlled Trial in Subjects at Ultra-high Risk for Psychosis With Omega-3 Fatty Acids in Europe (PURPOSE)

Ultra High Risk for Psychosis

Spain, Austria, Germany, Israel, Italy, Netherlands, Norway, Switzerland, United Kingdom
Novartis Pharmaceuticals

Completed

Adherence and Persistence to Inclisiran Among Early Users in Germany

High Levels of Low-density Lipoprotein Cholesterol

Switzerland
AO Clinical Investigation and Publishing Documentation
Ossacur Inc.

Terminated

Open Wedge High Tibia Osteotomy

High Tibia Osteotomy

Switzerland, Germany
Hypertension Excellence Centre Lucerne

Recruiting

Swiss Longitudinal Cohort

Cardiovascular Risk Factors

Switzerland
Karsten Königstein
University of Basel; QIAGEN Gaithersburg, Inc

Completed

VascuFit: Exercise and Vascular Aging (VascuFit)

Aerobic Exercise | Endothelial Function | Middle-aged Adults Sedentary, Elevated CV-risk)

Switzerland
Brigham and Women's Hospital
National Institute of Mental Health (NIMH); Yale University; Orygen

Recruiting

AMP SCZ® Observational Study: PREDICT-DPACC (AMP SCZ)

Psychosis | Remission | Conversion | Clinical High Risk

United States, United Kingdom, Canada, Italy, Australia, Chile, China, Denmark, Germany, Hong Kong, Korea, Republic of, Singapore, Spain, Switzerland
University Hospital, Basel, Switzerland

Terminated

The Basel Enteral High Protein Study

Autophagy | High Enteral Protein Nutrition | Muscle Breakdown

Switzerland
University Hospital, Basel, Switzerland

Completed

Triage - Symptoms and Other Predictors in an All-comer Emergency Department Population (EMERGE VI)

Triage Risk Stratification

Switzerland
University Hospital, Basel, Switzerland

Completed

Triage - Symptoms and Other Predictors in an All-comer Emergency Department Population; (EKBB 236/13) (EMERGE IV)

Triage Risk Stratification

Switzerland
Novartis Pharmaceuticals

Terminated

Phase III Study Investigating the Efficacy and Safety of Ruxolitinib in Early Myelofibrosis Patients With High Molecular Risk Mutations. (ReTHINK)

Myelofibrosis With High Molecular Risk Mutations

Belgium, Spain, United Kingdom, Hungary, Italy, Japan, Taiwan, Germany, Canada, Singapore, Austria, Australia, France, Israel, Sweden, Switzerland, Hong Kong, Greece, Turkey, Brazil, Russian Federation, Denmark, Portugal, Norway, Poland
University of Lausanne Hospitals

Completed

MRI of the Chest Under High Frequency Ventilation

Healthy Volunteer | Non-invasive Ventilation | High-frequency Ventilation

Switzerland
Insel Gruppe AG, University Hospital Bern

Not yet recruiting

CT-guided Lung Biopsy Risk Optimization Method (BROM-I)

Pneumothorax | Risk Factors | Biopsy, Needle | Radiology, Interventional

Switzerland
University of Zurich
University of Calgary

Completed

Effect of High Altitude Exposure, Acclimatization and Re-exposure on Cerebral Autoregulation in Lowlanders

Effect of High Altitude

Switzerland
University of Zurich
Kliniken Valens

Completed

Sensing Physical Activity to Evaluate and Monitor a Routine Aftercare Program (SensE-M) (SensE-M)

Disease With a Risk for Chronicity

Switzerland
University of Zurich
University of Calgary

Completed

Effect of High Altitude Exposure, Acclimatization and Re-exposure on Lung Water Content by Ultrasound

Effect of High Altitude

Switzerland
University of Zurich
University of Calgary

Completed

Effect of High Altitude Exposure, Acclimatization and Re-exposure on Right Ventricular Function in Lowlanders

Effect of High Altitude

Switzerland
University of Zurich

Completed

Effect of High Altitude Exposure, Acclimatization and Re-exposure on Postural Control in Lowlanders

Effect of High Altitude

Switzerland
University Hospital Inselspital, Berne
Edwards Lifesciences

Completed

Pulse Contour Analysis and Tissue Oxymetry in Changing Vascular Tone

Vasodilation | Vasoconstriction | Hemodynamics | Cardiac Output, Low | Cardiac Output, High

Switzerland
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma

Recurrent Neuroblastoma | Localized Resectable Neuroblastoma | Localized Unresectable Neuroblastoma | Regional Neuroblastoma | Stage 4S Neuroblastoma | Stage 4 Neuroblastoma

United States, Canada, Australia, New Zealand, Puerto Rico, Switzerland
University of Zurich
National Center of Cardiology and Internal Medicine named after academician...

Completed

Kyrgyz Asthma Rehabilitation at High Altitude

Effect of High Altitude

Switzerland
University of Zurich
Swiss Tropical & Public Health Institute

Completed

TOURIST 2: Tracking Of Urgent Risks In Swiss Travelers (TOURIST2)

Risk Behavior | Travel Health | Mobile Health Technology (mHealth) | Elderly Travelers | Chronic Diseased Travelers

Switzerland
University Hospital, Geneva

Completed

Visceral Obesity and Colorectal Surgery

Colorectal Surgery | Visceral Obesity | Risk Factor

Switzerland
Centre Hospitalier Universitaire Vaudois

Unknown

Evaluation of Prolonged Apnea Supported by High Frequency Non-invasive Ventilation. (ANIV)

Lung Diseases | Healthy Volunteer | Non-invasive Ventilation | High-frequency Ventilation

Switzerland
Edwards Lifesciences

Completed

Using Minimally Invasive Cardiac Output Data vs. Standard Care for Patients Emergently Admitted to the Intensive Care Unit Who Are Hemodynamically Unstable

Cardiac Output, Low | Cardiac Output, High

Switzerland, Finland
Insel Gruppe AG, University Hospital Bern
ETH Zurich

Not yet recruiting

Swiss 2024 Continous Fever Monitoring in Pediatric Oncology Patients

Pediatric Oncology Patients With Risk for Infections

Switzerland
Children's Oncology Group
National Cancer Institute (NCI)

Recruiting

Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma

Localized Resectable Neuroblastoma | Localized Unresectable Neuroblastoma | Regional Neuroblastoma | Stage 4S Neuroblastoma | Ganglioneuroblastoma | Stage 4 Neuroblastoma

United States, Puerto Rico, Canada, Australia, New Zealand, Netherlands, Saudi Arabia, Switzerland
Assistance Publique - Hôpitaux de Paris

Completed

Precision Risk Stratification in Kidney Transplant Patients - EU-TRAIN (EU-TRAIN)

Kidney Transplantation | Kidney Transplant Rejection | Prognosis | Risk Stratification

France, Germany, Spain, Switzerland
Urs E. Nydegger
Labormedizinisches Zentrum Dr. Risch

Unknown

Impact of Oral Glucose Tolerance Test on Extent of Hemoglobin Glycation (HbA1c)

Blood Glucose, High | Oral Hypoglycaemic Overdose

Switzerland
University of Zurich
University of Calgary

Completed

Effect of High Altitude Exposure, Acclimatization and Re-exposure on Nocturnal Breathing Pattern in Lowlanders

Effect of High Altitude

Switzerland
University Hospital, Basel, Switzerland
University Basel, Department of Sport, Exercise and Health, Division of Sport...

Completed

Glioma and Exercising

High Grade Glioma

Switzerland
Amsterdam UMC

Recruiting

Prospective Endoscopic Follow-up of Patients With Submucosal and High Risk Mucosal Esophageal Adenocarcinoma (PREFER)

Barrett Esophagus | Submucosal Esophageal Adenocarcinoma | High-risk Mucosal Esophageal Adenocarcinoma

Netherlands, Belgium, Australia, United Kingdom, Germany, Switzerland
Academisch Medisch Centrum - Universiteit van Amsterdam...

Unknown

Outcomes of Endoscopically Resected High-risk Mucosal and Low- and High-risk Submucosal Adenocarcinoma Arising in Barrett's Esophagus

Barrett Esophagus | Adenocarcinoma Esophagus | Submucosal Esophageal Adenocarcinoma | High-risk Mucosal Esophageal Adenocarcinoma

France, United Kingdom, Belgium, Germany, Switzerland, Australia, Netherlands
University Hospital Inselspital, Berne

Completed

Pedometer Activity Monitoring After ASCT (PAMAL)

Lymphoma | Myeloma | Autologous Stem Cell Transplantation | High-dose Chemotherapy

Switzerland
Bristol-Myers Squibb

Completed

Efficacy Study of Ipilimumab Versus Placebo to Prevent Recurrence After Complete Resection of High Risk Stage III Melanoma

High Risk Stage III Melanoma

Italy, Poland, United Kingdom, United States, Netherlands, Spain, Australia, France, Germany, Canada, Russian Federation, Belgium, Norway, Switzerland, Sweden, Finland, Austria, Denmark, Czechia
University of Zurich

Completed

Altitude Related Adverse Health Effects (ARAHE) in Patients With Precapillary Pulmonary Hypertension During 30h Exposure to 2500m

High Altitude Pulmonary Hypertension

Switzerland
University of Zurich

Completed

Exercise Endurance Time on the 2nd Day at 2500 m High Altitude

High Altitude Pulmonary Hypertension

Switzerland
Michael Rufer
University of Zurich

Enrolling by invitation

Integrated Care After Repeated Psychiatric Hospital Stays - Evaluation of an Interdisciplinary Treatment Program (INTUK)

Health Care Utilization | Chronic Psychiatric Disorder | Psychiatric Hospitalization | Intensive Care Psychiatric Disorder | Rehospitalization | High Utilization / Heavy Use

Switzerland
ECRI bv
University of Bern; European Cardiovascular Research Center; Terumo Medical Corporation and other collaborators

Completed

Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated Versus Prolonged DAPT Regimen (MASTER DAPT)

Coronary Artery Disease | PCI | High Bleeding Risk

Netherlands, France, United Kingdom, Australia, Singapore, Japan, Italy, Poland, Spain, Switzerland, Israel, Argentina, Austria, Bahrain, Bangladesh, Belgium, Bulgaria, Czechia, Denmark, Estonia, Germany, Hungary, India, Korea, Republic... and more
University of Zurich

Completed

Nocturnal Oxygenation and Sleep-related Breathing Disorders During the First Night of a Stay at 2500m of High Altitude in Patients With Precapillary Pulmonary Hypertension

Sleep | High Altitude Pulmonary Hypertension

Switzerland
University of Zurich

Completed

Effect of Oxygen Therapy for Patients With Precapillary Pulmonary Hypertension Who Experience an Altitude Related Adverse Health Effect (ARAHE) During 30h Exposure to 2500m

Oxygen Therapy | High Altitude Pulmonary Hypertension

Switzerland
University Hospital, Basel, Switzerland

Recruiting

Effect of Monitoring Continuous Glucose Levels and Physical Activity Via Wearables on Cardiovascular Risk Factors

Physical Activity | Coronary Heart Disease | Cardiovascular Risk Factors

Switzerland
University of Zurich

Completed

Maximal Exercise Capacity at 2500 m of High Altitude

High Altitude Pulmonary Hypertension | Maximal Exercise Capacity

Switzerland
St. Anna Clinic Luzern

Completed

Lumbar Spine Surgery: Regional vs. General Anaesthesia

Herniated Disk Lumbar

Switzerland
University of Zurich
Wroclaw Medical University

Unknown

The Global PCHF-COVICAV Registry (PCHF-COVICAV)

Cardiovascular Diseases | Heart Failure | COVID-19 | Cardiovascular Risk Factor

Switzerland
Klinik Valens

Recruiting

Transient and Immediate Motor Effects of Exercise in Progressive Multiple Sclerosis (TIME)

Multiple Sclerosis, Chronic Progressive | High-Intensity Interval Training | Motor Symptoms

Switzerland
Ablynx, a Sanofi company

Completed

Comparative Study of ALX-0081 Versus GPIIb/IIIa Inhibitor in High Risk Percutaneous Coronary Intervention (PCI) Patients

Unstable Angina | Non ST Segment Elevation Myocardial Infarction (NSTEMI) | Stable Angina (Associated With High Risk PCI)

Poland, Belgium, Germany, Israel, Austria, Switzerland, Czechia

Clinical Trials on High-Risk Neuroblastoma in Switzerland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Madagascar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations